ESR1 and breast carcinoma: Lack of ER expression in human breast cancer cells is characterised by estrogen independent proliferation, and up to 40% of human breast cancer represent this phenotype.8,9,23 Adjuvant treatment strategies consist of chemotherapeutics, and of trastuzumab in case of positive HER-2 receptor status.